 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
15 May 1998 | Volume 128 Issue 10 | Pages 829-832
Background: Vitamin K deficiency may be associated with osteoporosis.
Objective: To assess the effects of warfarin on bone.
Design: Prospective observational study.
Setting: Four centers in the United States.
Participants: 6201 elderly, postmenopausal women.
Measurements: Self-reported warfarin use, bone mineral density at the hip and the heel, hip bone loss over 2 years, and fractures during 3.5 years of follow-up. Analyses were adjusted for baseline differences, age, weight, and estrogen use.
Results: Compared with warfarin nonusers (n = 6052), warfarin users (n = 149) more frequently had poor health, involuntary weight loss, nonthiazide diuretic use, and frailty but had similar bone mineral density at the hip (difference, 1.6% [95% CI, –0.7% to 4.1%]) and heel (difference, 2.1% [CI, –1.6% to 5.6%]). Users and nonusers had similar rates of bone loss (1.1% and 0.8%; P = 0.18) and fractures (relative hazard, 1.0 [CI, 0.60 to 1.7]).
Conclusion: In this population, warfarin use did not decrease bone mineral density or increase fracture rates.
Author and Article Information
For the Study of Osteoporotic Fractures Research Group*
BRIEF COMMUNICATION
Warfarin Use and Risk for Osteoporosis in Elderly Women
From University of California, San Francisco, and San Francisco Veterans Affairs Medical Center, San Francisco, California.
*For members of the Study of Osteoporotic Fractures Research Group, see Ann Intern Med. 1996; 124:187-96.
Acknowledgments: The authors thank Dr. Ahmed Bayoumi for helpful comments on earlier versions of this paper.
Grant Support: By grants AG05407, AR35582, AG05394, AM35584, AR35583, and NS36016 from the National Institutes of Health, Public Health Service.
Requests for Reprints: Sophie A. Jamal, MD, Prevention Sciences Group, Suite 512, 74 New Montgomery Street, San Francisco, CA 94105; e-mail sophie_jamal@quickmail.ucsf.edu.
Current Author Addresses: Dr. Jamal: Suite 512, 74 New Montgomery Street, San Francisco, CA 94105.
This article has been cited by other articles:
|
|
 |
|
  L. D. Carbone, J. D. Cross, S. H. Raza, A. J. Bush, R. J. Sepanski, S. Dhawan, B. Q. Khan, M. Gupta, K. Ahmad, R. N. Khouzam, et al. Fracture Risk in Men With Congestive Heart Failure: Risk Reduction With Spironolactone J. Am. Coll. Cardiol., July 8, 2008; 52(2): 135 - 138. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. M Macdonald, F. E McGuigan, S. A Lanham-New, W. D Fraser, S. H Ralston, and D. M Reid Vitamin K1 intake is associated with higher bone mineral density and reduced bone resorption in early postmenopausal Scottish women: no evidence of gene-nutrient interaction with apolipoprotein E polymorphisms Am. J. Clinical Nutrition, May 1, 2008; 87(5): 1513 - 1520. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Pearson Bone Health and Osteoporosis: The Role of Vitamin K and Potential Antagonism by Anticoagulants Nutr Clin Pract, October 1, 2007; 22(5): 517 - 544. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. B. Goodman, W. Jiranek, E. Petrow, and A. W. Yasko The Effects of Medications on Bone J. Am. Acad. Ortho. Surg., August 1, 2007; 15(8): 450 - 460. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Sugiyama, T. Takaki, K. Sakanaka, H. Sadamaru, K. Mori, Y. Kato, T. Taguchi, and T. Saito Warfarin-induced impairment of cortical bone material quality and compensatory adaptation of cortical bone structure to mechanical stimuli J. Endocrinol., July 1, 2007; 194(1): 213 - 222. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Cummings A 55-Year-Old Woman With Osteopenia JAMA, December 6, 2006; 296(21): 2601 - 2610. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. F. Gage, E. Birman-Deych, M. J. Radford, D. S. Nilasena, and E. F. Binder Risk of Osteoporotic Fracture in Elderly Patients Taking Warfarin: Results From the National Registry of Atrial Fibrillation 2 Arch Intern Med, January 23, 2006; 166(2): 241 - 246. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. W Nieves Osteoporosis: the role of micronutrients Am. J. Clinical Nutrition, May 1, 2005; 81(5): 1232S - 1239S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Bern Observations on Possible Effects of Daily Vitamin K Replacement, Especially Upon Warfarin Therapy JPEN J Parenter Enteral Nutr, November 1, 2004; 28(6): 388 - 398. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Sangle, D P D'Cruz, M A Khamashta, and G R V Hughes Antiphospholipid antibodies, systemic lupus erythematosus, and non-traumatic metatarsal fractures Ann Rheum Dis, October 1, 2004; 63(10): 1241 - 1243. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. C Binkley, D. C Krueger, T. N Kawahara, J. A Engelke, R. J Chappell, and J. W Suttie A high phylloquinone intake is required to achieve maximal osteocalcin {gamma}-carboxylation Am. J. Clinical Nutrition, November 1, 2002; 76(5): 1055 - 1060. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G Ruiz-Irastorza, M A Khamashta, and G R. Hughes Heparin and osteoporosis during pregnancy: 2002 update Lupus, October 1, 2002; 11(10): 680 - 682. [Abstract] [PDF]
|
|
|
|
|
|
N. C Binkley, D. C Krueger, J. A Engelke, A. L Foley, and J. W Suttie Vitamin K supplementation reduces serum concentrations of under-{gamma}-carboxylated osteocalcin in healthy young and elderly adults Am. J. Clinical Nutrition, December 1, 2000; 72(6): 1523 - 1528. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Z. Ilich and J. E. Kerstetter Nutrition in Bone Health Revisited: A Story Beyond Calcium J. Am. Coll. Nutr., June 1, 2000; 19(6): 715 - 737. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Caraballo, J. A. Heit, E. J. Atkinson, M. D. Silverstein, W. M. O'Fallon, M. R. Castro, and L. J. Melton III Long-term Use of Oral Anticoagulants and the Risk of Fracture Arch Intern Med, August 9, 1999; 159(15): 1750 - 1756. [Abstract] [Full Text] [PDF]
|
|
Article
